Remeglurant (; developmental code name MRZ-8456) is a
drug
A drug is any chemical substance that causes a change in an organism's physiology or psychology when consumed. Drugs are typically distinguished from food and substances that provide nutritional support. Consumption of drugs can be via inhal ...
which acts as a
selective antagonist of the
mGlu5 receptor.
It is under development by Merz Pharmaceuticals for the treatment of
drug-induced dyskinesia but no development has been reported since at least 2016.
See also
*
Basimglurant
*
Dipraglurant
*
Fenobam
*
Mavoglurant
*
Raseglurant
References
Isoquinolines
MGlu5 receptor antagonists
Organobromides
Pyrimidines
{{Nervous-system-drug-stub